Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL106854

CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC.O=C([O-])c1ccccc1C(=O)[O-]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.47
CYP3A4 P08684 2/20 0.47
TP53 P04637 1/20 0.47
MAPK1 P28482 1/20 0.47
ALDH1A1 P00352 3/20 0.46
LMNA P02545 2/20 0.46
SLC22A1 O15245 2/20 0.44
HTT P42858 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CES2 O00748 3/20 0.43
CES1 P23141 3/20 0.43
HPGD P15428 3/20 0.43
KDM4E B2RXH2 2/20 0.42
NAAA Q02083 1/20 0.41
MEN1 O00255 1/20 0.41
NR1I2 O75469 1/20 0.41
CHRM2 P08172 1/20 0.41
ADRA2A P08913 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL28459959 0.93 TSHR (0.42) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrabuthylammonium SCHEMBL106856 0.93 ALDH1A1 (0.47) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrabuthylammonium SCHEMBL28624852 0.92 CYP3A4 (0.50) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrabuthylammonium SCHEMBL3702709 0.91 TSHR (0.44) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrabuthylammonium SCHEMBL107740 0.90 KDM4E (0.59) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrapropylammonium SCHEMBL105669 0.89 ALDH1A1 (0.45) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrabuthylammonium SCHEMBL23539134 0.89 TSHR (0.41) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrabuthylammonium SCHEMBL7188512 0.89 MAPT (0.42) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrabuthylammonium SCHEMBL1684318 0.89 HPGD (0.51) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrabuthylammonium SCHEMBL23522665 0.89 HDAC3 (0.49) TSHRCYP3A4TP53MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260118767-A1 REVERSE PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-04-30 US disclosed
US-20260044081-A1 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-02-12 US disclosed
EP-4692941-A2 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS Shin-Etsu Chemical Co., Ltd. (JP) 2026-02-11 EP disclosed
EP-4621486-A2 POLYVALENT AMMONIUM SALT COMPOUND, COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-09-24 EP disclosed
US-20250289931-A1 POLYVALENT AMMONIUM SALT COMPOUND, COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-09-18 US disclosed
EP-4592299-A1 SILICON-CONTAINING SULFONIUM SALT COMPOUND, COMPOSITION FOR FORMING A SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-07-30 EP disclosed
US-20250237953-A1 SILICON-CONTAINING SULFONIUM SALT COMPOUND, COMPOSITION FOR FORMING A SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-07-24 US disclosed
US-12332567-B2 Composition for forming silicon-containing resist underlayer film, patterning process, and silicon compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-06-17 US disclosed
US-12332565-B2 Thermosetting iodine- and silicon-containing material, composition containing the material for forming resist underlayer film for EUV lithography, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-06-17 US disclosed
CN-112526822-B Composition for forming silicon-containing resist underlayer film and pattern forming method 信越化学工业株式会社 2025-02-28 CN disclosed
EP-0651023-B1 Curable resin composition for coating uses NIPPON PAINT CO LTD (JP) 1999-07-14 EP disclosed
EP-0737726-B1 One-component, thermosetting resin composition for coating use NIPPON PAINT CO LTD (JP) 1999-07-14 EP disclosed
US-5911099-A Electroconductiive member and electrophotogrpahic apparatus BRIDGESTONE CORPORATION (JP) 1999-06-08 US disclosed
US-5827928-A MICHAEL REACTION CURABLE; CATALYZED WITH A QUATERNARY COMPOUND IN THE PRESENCE OF A FIVE-MEMBERED CYCLIC CARBONATE NIPPON PAINT CO., LTD. (JP) 1998-10-27 US disclosed
EP-0808860-A2 Curable resin composition for coating use NIPPON PAINT CO., LTD. (JP) 1997-11-26 EP disclosed
EP-0737726-A1 One-component, thermosetting resin composition for coating use Nippon Paint Co., Ltd. (JP) 1996-10-16 EP disclosed
US-5565525-A CURABLE THROUGH MICHAEL REACTION NIPPON PAINT CO., LTD. (JP) 1996-10-15 US disclosed
EP-0651023-A2 Curable resin composition for coating uses Nippon Paint Co., Ltd. (JP) 1995-05-03 EP disclosed
US-5200472-A Alkyl acrylate, alkoxyalkyl acrylate, epoxy-containing vinyl monomer, unsaturated aryl ester; diphenyl phthalate, quaternary ammonium, phosphonium, urea or guanidine crosslinkers NIPPON MEKTRON, LIMITED (JP) 1993-04-06 US disclosed
US-4324885-A QUATERNARY AMMONIUM OR PHOSPHONIUM CATALYST GENERAL ELECTRIC COMPANY (US) 1982-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12332567-B2 Composition for forming silicon-containing resist underlayer film, patterning process, and silicon compound SMC1A, CDH1, SMC4 TSHR 4787/4885CYP3A4 1736/4885TP53 3039/4885
US-20250289931-A1 POLYVALENT AMMONIUM SALT COMPOUND, COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS ASH2L, PUF60, IDUA TSHR 3217/4885CYP3A4 4669/4885TP53 4698/4885
US-12332565-B2 Thermosetting iodine- and silicon-containing material, composition containing the material for forming resist underlayer film for EUV lithography, and patterning process RPS4X, SIK3, MLX TSHR 439/4885CYP3A4 3839/4885TP53 4176/4885
US-20260118767-A1 REVERSE PATTERNING PROCESS EFNA1, EPHA4, ETV6 TSHR 770/4885CYP3A4 3527/4885TP53 2594/4885
US-20260044081-A1 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS SMC1A, SPOUT1, LBR TSHR 446/4885CYP3A4 2742/4885TP53 4717/4885
US-20250237953-A1 SILICON-CONTAINING SULFONIUM SALT COMPOUND, COMPOSITION FOR FORMING A SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS SMURF1, OSR1, SIK1 TSHR 2745/4885CYP3A4 4523/4885TP53 4703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.